ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $25,000 | -10.7% | 17,395 | -12.3% | 0.00% | – |
| Q4 2016 | $28,000 | -73.1% | 19,832 | -66.5% | 0.00% | -100.0% |
| Q3 2016 | $104,000 | -21.8% | 59,202 | -23.8% | 0.00% | 0.0% |
| Q2 2016 | $133,000 | -13.6% | 77,739 | -0.6% | 0.00% | 0.0% |
| Q1 2016 | $154,000 | +32.8% | 78,233 | +27.7% | 0.00% | 0.0% |
| Q4 2015 | $116,000 | +5.5% | 61,278 | +6.1% | 0.00% | 0.0% |
| Q3 2015 | $110,000 | -52.6% | 57,767 | +15.6% | 0.00% | -50.0% |
| Q2 2015 | $232,000 | +6.9% | 49,980 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $217,000 | +26.9% | 49,748 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $171,000 | -16.6% | 49,329 | +0.7% | 0.00% | -33.3% |
| Q3 2014 | $205,000 | -28.1% | 48,980 | +0.6% | 0.00% | -25.0% |
| Q2 2014 | $285,000 | -10.7% | 48,670 | -3.8% | 0.00% | 0.0% |
| Q1 2014 | $319,000 | +13.1% | 50,567 | +4.9% | 0.00% | 0.0% |
| Q4 2013 | $282,000 | +8.5% | 48,206 | -2.3% | 0.00% | -20.0% |
| Q3 2013 | $260,000 | -34.2% | 49,335 | -3.8% | 0.01% | -44.4% |
| Q2 2013 | $395,000 | – | 51,309 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |